Vanguards of Healthcare by Bloomberg Intelligence – Détails, épisodes et analyse

Détails du podcast

Informations techniques et générales issues du flux RSS du podcast.

Vanguards of Healthcare by Bloomberg Intelligence

Bloomberg

Business & Entrepreneuriat

Forme & Santé

Fréquence : 1 épisode/8j. Total Éps: 150

Vanguards of Healthcare is a series of exclusive conversations with management teams and thought leaders discussing changes on the forefront of the industry, including innovations in medical products and technologies, advances in clinical research, new service models, wellness and regulations.

Lire plusRéduire

Site

RSS

Apple

Classements récents

Dernières positions dans les classements Apple Podcasts et Spotify.

Apple Podcasts

🇬🇧 Grande Bretagne - investing
24/06/2026
#83
🇬🇧 Grande Bretagne - investing
23/06/2026
#70
🇫🇷 France - investing
10/06/2026
#86

Spotify

Aucun classement récent disponible

Liens partagés entre épisodes et podcasts

Liens présents dans les descriptions d'épisodes et autres podcasts les utilisant également.

https://omnystudio.com/listener
147 partages

Qualité et score du flux RSS

Évaluation technique de la qualité et de la structure du flux RSS.

Qualité du flux RSS

À améliorer

Score global : 48%

Historique des publications

Répartition mensuelle des publications d'épisodes au fil des années.

Year

Derniers épisodes publiés

Liste des épisodes récents, avec titres, durées et descriptions.

AstraZeneca’s ASCO Readout on Oncology’s Next Wave

mardi 9 juin 2026 • Durée 57:59

“I think it’s the most exciting period in cancer discovery and development that I’ve experienced over the last 25 years,” says Susan Galbraith, executive vice president of oncology R&D at AstraZeneca. Galbraith joins Bloomberg Intelligence analyst Sam Fazeli fresh from the ASCO conference to unpack how ctDNA, earlier intervention and next-generation oncology platforms could reshape cancer care. They discuss AstraZeneca’s Stride regimen in liver cancer, Serena-6 in breast cancer, progress in pancreatic cancer and the company’s push across ADCs, bispecifics, CAR-T and radio conjugates.

See omnystudio.com/listener for privacy information.

Lire plusRéduire

Ocular Therapeutix Cuts Blindness Toll

jeudi 28 mai 2026 • Durée 23:50

“Forty percent of patients in this country alone in the first year drop out [of current retinal disease treatments] and every one of those patients ends up going blind. By far the most expensive disease in the world is blindness and the reason for that is really quite simple. It’s because the mortality doesn’t change, the use of resources skyrockets, but the mortality doesn’t change. In this country, every blind patient costs over $66,000 a year,” says Pravin Dugel, CEO of Ocular Therapeutix. “If we reduce that dropout rate by even 10% with Axpaxli, and I’m sure we’ll do even better, we’re talking about a quarter million fewer patients in this country alone who will not go blind. The impact of that, not just on a human basis but on an economic basis, is astronomical.” In this episode of the Vanguards of Healthcare podcast, Pravin sits down with Bloomberg Intelligence senior analyst Ann-Hunter van Kirk to discuss how the company can reduce the therapeutic and economic burden of retinal diseases.

See omnystudio.com/listener for privacy information.

Lire plusRéduire

Inside Insilico Medicine’s AI Strategy and Lilly Breakthrough

mardi 31 mars 2026 • Durée 59:53

“This deal [with Eli Lilly, announced on Sunday 29 March] is a combination of an asset licensing and collaboration. We’ve collaborated with Lilly in the past and they are actually one of the most active and expert users of our software,” says Alex Zhavoronkov, founder and co-CEO of Insilico Medicine. Zhavoronkov joins Bloomberg Intelligence pharmaceuticals analyst Sam Fazeli to explain how Insilico is using AI to compress drug-discovery timelines from years to months, pursue novel targets and compete with both big pharma and China’s fastest-moving biotech players. They also discuss the company’s rapid Lilly deal and why AI’s real edge may be before the clinic, not inside it.

See omnystudio.com/listener for privacy information.

Lire plusRéduire

EDAP’s Robot Treats Prostate Cancer

jeudi 20 juin 2024 • Durée 42:12

EDAP can treat prostate cancer by focusing ultrasound waves at just the target region, similar to how a magnify glass can focus light from the sun so intensely that it can burn a piece of paper, allowing it to eliminate the cancer while limiting side effects, CEO Ryan Rhodes explains to Bloomberg Intelligence. In this Vanguards of Health Care episode, Rhodes sits down with BI analyst Matt Henriksson to talk about his path from Intuitive Surgical to lead EDAP, how the Focal One robot uses high intensity focused ultrasound, or HIFU, to ablate prostate cancer without needing an incision or removing the whole prostate and how the HIFI Study shows that Focal One can be a viable alternative to radical prostatectomy.

See omnystudio.com/listener for privacy information.

Lire plusRéduire

Haemonetics Diversifies Into New Form

jeudi 13 juin 2024 • Durée 47:32

Haemonetics, a medical-device maker that focuses on markets including blood and plasma collection, is evolving to expand broadly with more diversification and greater sustainability over time, all with the view that good products win, CEO Chris Simon explains to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Simon sits down with BI analyst Matt Henriksson to talk about Haemonetics and how its has built out its hospital franchise with M&A to include high-growth segments that diversifies the company beyond its traditional blood and plasma collection businesses. He also shares his views on how medtech companies need to have products with competitive advantages as the hospital environment rationalizes and whittles down the number of medtech suppliers they use.

See omnystudio.com/listener for privacy information.

Lire plusRéduire

OrthoPediatrics’ Focus on Helping Kids

jeudi 6 juin 2024 • Durée 43:12

OrthoPediatrics’ aspiration is to develop anatomically appropriate implants, instruments and specialized braces for children, so surgeons don’t need to “MacGyver” their way with treating a child with adult sized devices, CEO David Bailey explains to Bloomberg Intelligence, referring to the multi-skilled character from the 1980s TV series. In this Vanguards of Health Care podcast episode, Bailey sits down with BI analyst Matt Henriksson for an in-depth interview to talk about OrthoPediatrics, how its technology built a cohesive commercial model to aid pediatric orthopedic surgeons, including products and clinical support, and how it has developed a strong M&A platform to add innovation to its portfolio.

See omnystudio.com/listener for privacy information.

Lire plusRéduire

Personify Health Pioneering Personalized Care Through AI

jeudi 30 mai 2024 • Durée 45:37

“We’re staking the company on personalization: If you can make the health-care experience more personal to the individual, they’ll be more likely to engage around their health care and take the proper actions to get better outcomes,” Chris Michalak, CEO of Personify Health, tells Bloomberg Intelligence in this episode of the Vanguards of Health Care podcast. Michalak joins BI analyst Jonathan Palmer to discuss the merger of Virgin Pulse and HealthComp, the company’s AI-driven personalization engine and the value proposition for employers. The conversation also covers Personify’s approach to consolidation in health care, the role of navigation and the impact of GLP-1 drugs on the market.

See omnystudio.com/listener for privacy information.

Lire plusRéduire

Bolt Brings iOS Tech to Spine Surgery

jeudi 23 mai 2024 • Durée 49:48

Bolt Navigation has shrunk the use of a navigation system for spine surgery into an Apple iOS device, using the gyroscope-on-chip technology to make spinal fusion cases more accurate in any surgery setting, CEO Patrick West says. In this episode of Bloomberg Intelligence’s Vanguards of Health Care podcast, West sits down with BI analyst Matt Henriksson to talk about how the Bolt Navigation Unit leverages the gyroscope and an X-ray acquired once the patient is positioned for pedicle screw placement, with no special imaging required during the procedure. West goes on to say how this technology can penetrate ambulatory surgical centers, that can perform simple spinal fusion cases without a robot they may not be able to afford

See omnystudio.com/listener for privacy information.

Lire plusRéduire

Alto Is Aiming to Redefine Psychiatry

jeudi 16 mai 2024 • Durée 36:22

Modern medicine hasn’t made big strides in managing psychiatric disorders, a growing challenge with global implications. “The treatment of psychiatric disorders hasn’t changed from what it was like 30 years ago, medications are given by trial and error and we don’t really know what’s going to work,” Amit Etkin, CEO of Alto Neuroscience, tells Bloomberg Intelligence in this episode of the Vanguards of Health Care podcast. BI senior health-care associate Jean Rivera Irizarry joins Dr. Etkin for an in-depth interview about Alto, how it was formed, its drug-selection process and how the company aims to redefine the way we treat such disorders.

See omnystudio.com/listener for privacy information.

Lire plusRéduire

Vericel Advances Use of Cell Therapies

vendredi 10 mai 2024 • Durée 46:32

Vericel acquired a hidden gem in cartilage repair that other companies had written off, and developed it into a high-growth product that could potentially address a $4 billion market. In this episode of the Vanguards of Health Care podcast, Vericel CEO Nick Colangelo sits down with Matt Henriksson, Bloomberg Intelligence analyst, to talk about how MACI took over as the market leader for cartilage repair in the knee and its potential to do so for the ankle. Colangelo also discusses why the company built a diversified portfolio and how NexoBrid complements its Epicel platform to fill out the company’s burn-care offerings.

See omnystudio.com/listener for privacy information.

Lire plusRéduire

Podcasts Similaires Basées sur le Contenu

Découvrez des podcasts liées à Vanguards of Healthcare by Bloomberg Intelligence. Explorez des podcasts avec des thèmes, sujets, et formats similaires. Ces similarités sont calculées grâce à des données tangibles, pas d'extrapolations !

À propos Méthodologie Contact Me soutenir Politique de confidentialité

Vanguards of Healthcare by Bloomberg Intelligence – Détails, épisodes et analyse

Détails du podcast

Classements récents

Apple Podcasts

Spotify

Liens partagés entre épisodes et podcasts

Other1

Qualité et score du flux RSS

Historique des publications

Derniers épisodes publiés

Podcasts et contenus similaires

Podcasts Similaires Basées sur le Contenu

Apple Podcasts

Spotify

Other1

Podcasts Similaires Basées sur le Contenu